Advances in stem cell biology over the past decade have fueled interestin new therapies for acute and chronic cardiovascular diseases.Pre-clinical work with a variety of cell types has suggested efficacyin improving ischemia and ventricular function, although mechanisms ofeffect remain to be fully explained. Human studies using certain cell typeshave shown modest clinical efficacy, while the safety of these experimentaltherapies supports continuing patient-oriented research.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
